Company Profiles

driven by the PitchBook Platform

Otic Pharma

Description

Developer of drugs for disorders of the ear, nose, and throat (ENT). The company provides products for the treatment of ENT disorders, based on FoamOtic, a proprietary foam-based drug delivery system providing sustained exposure of drugs. Its products includes a nasally-administered, combination drug product (OP-02) intended to address the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD).

2008

Founded

PRIVATE

Status

1-10

Employees

Reverse Merger

Latest Deal Type

$4.3M

Total Amount Raised

6

Investors

Description

Developer of drugs for disorders of the ear, nose, and throat (ENT). The company provides products for the treatment of ENT disorders, based on FoamOtic, a proprietary foam-based drug delivery system providing sustained exposure of drugs. Its products includes a nasally-administered, combination drug product (OP-02) intended to address the underlying cause of otitis media and Eustachian tube dysfunction (OM/ETD).

Website:

www.oticpharma.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

19900 MacArthur Boulevard Suite 550 Irvine, CA 92612United States +1 (949) 238-8090
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Otic Pharma's full profile, request a free trial.

Otic Pharma Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Otic Pharma Investors (6)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Incentive IncubatorAccelerator/Incubator000 0000000 0000
Individual InvestorAngel (individual)Minority000 0000000 0000
OrbiMedVenture CapitalMinority000 0000000 0000
Peregrine VenturesVenture CapitalMinority000 0000000 0000
Pontifax Venture CapitalVenture CapitalMinority000 0000000 0000
Incentive Incubator Accelerator/Incubator
Individual Investor Angel (individual)
OrbiMed Venture Capital
Peregrine Ventures Venture Capital
Pontifax Venture Capital Venture Capital

Otic Pharma Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Gregory FlesherChief Executive Officer, President & Board Member
Christine OcampoChief Financial Officer & Senior Vice President
Rodrigo Yelin Ph.DChief Operating Officer & Head, Research & Development
Catherine Turkel Ph.DChief Development Officer
Michael CruseVice President, Corporate Operations
Gregory Flesher Chief Executive Officer, President & Board Member
Christine Ocampo Chief Financial Officer & Senior Vice President
Rodrigo Yelin Ph.D Chief Operating Officer & Head, Research & Development
Catherine Turkel Ph.D Chief Development Officer
Michael Cruse Vice President, Corporate Operations

Otic Pharma Board Members (8)

NameRepresentingRoleSinceContact
Info
Chen SchorSelfBoard Member000 0000
Eran Eilat MDSelfBoard Member000 0000
Erez ChimovitsOrbiMedSenior Managing Director000 0000
Eyal LifschitzPeregrine VenturesCo-Founder, Chief Executive Officer & General Partner000 0000
Gregory FlesherOtic PharmaChief Executive Officer, President & Board Member000 0000
Chen Schor Board Member Self
Eran Eilat MD Board Member Self
Erez Chimovits Senior Managing Director OrbiMed
Eyal Lifschitz Co-Founder, Chief Executive Officer & General Partner Peregrine Ventures
Gregory Flesher Chief Executive Officer, President & Board Member Otic Pharma
Request full access to PitchBook